Current Share Price:  
Night Market Research
Initial Report Date(2022/02/17)Share Price:NA  
Zynex: UnitedHealthcare Terminating Contract – An Undisclosed Loss That Accounts For 50%+ EBITDA
 Details Link >
Zynex: UnitedHealthcare Terminating Contract – An Undisclosed Loss That Accounts For 50%+ EBITDA We uncover evidence that UnitedHealthcare will remove Zynex from its network effective February 15, a seemingly material event undisclosed to investors Zynex will lose its largest payor and only national commercial network, a critical relationship which represented high margin revenue worth 50-100% of EBITDA
By     
QTinsight - Customized Global Investment Research
QTinsight.com and all of its information providers will not be liable for any errors,omissions,delays or interruptions in all the information and data on the QTinsight.com website or for any damages relating to your use of the information provided herein. All data,research findings,opinions and information herein, whether provided by QTinsight.com or by its users,should not be treated as professional investment advice.